Camber Pharmaceuticals Launches Generic Methylin®
Piscataway, NJ, April 30, 2018– Camber Pharmaceuticals is pleased to announce the addition of Methylphenidate Chewable Tablet to our growing portfolio of products.
Methylphenidate Chewable tablet is the generic version of Methylin®. Methylphenidate is used to treat attention deficit hyperactivity disorder- ADHD.
Methylphenidate Chewable tablets are available in 2.5, 5 and 10mg 100ct bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected]
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection